-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Titan Pharmaceuticals Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2011 to 2023.
- Titan Pharmaceuticals Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 914K shares, a 21.7% increase year-over-year.
- Titan Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 752K shares, a 11.9% increase from 2022.
- Titan Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 672K shares, a 93.1% decline from 2021.
- Titan Pharmaceuticals Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 9.73M shares, a 158% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)